Archive


Category: ~$15.0M

  • Inotiv to Acquire Plato BioPharma for ~$15.0M

    Shots: Inotiv to acquire Plato BioPharma for $15.0M that consist of $10.0M in cash, $2.0M in Inotiv’s common shares (57,587) based on the average closing price for 20 trading-day period ends on Sept 29, 2021, $3.0M in unsecured promissory notes The acquisition will bolster PBI’s growing discovery operations in the Boulder, Colorado & expands its […]